Abstract:Extracellular micro- and nanoscale membrane vesicles produced by different cells progressively attract the attention of the scientific community. They function as mediators of intercellular communication and transport genetic material and signaling molecules between the cells. In the context of keeping homeostasis, the extracellular vesicles contribute to the regulation of various systemic and local processes. Vesicles released by the tumor and activated stromal cells exhibit multiple functions including support of tumor growth, preparation of the pre-metastatic niches, and immune suppression. Considerable progress has been made regarding the criteria of classification of the vesicles according to their origin, content, and function: Exosomes, microvesicles, also referred to as microparticles or ectosomes, and large oncosomes were defined as actively released vesicles. Additionally, apoptotic bodies represented by a highly heterogeneous population of particles produced during apoptosis, the programmed cell death, should be considered. Because the majority of isolation techniques do not allow the separation of different types of vesicles, a joined term "extracellular vesicles" (EVs) was recommended by the ISEV community for the definition of vesicles isolated from either the cell culture supernatants or the body fluids. Because EV content reflects the content of the cell of origin, multiple studies on EVs from body fluids in the context of cancer diagnosis, prediction, and prognosis were performed, actively supporting their high potential as a biomarker source. Here, we review the leading achievements in EV analysis from body fluids, defined as EV-based liquid biopsy, and provide an overview of the main EV constituents: EV surface proteins, intravesicular soluble proteins, EV RNA including mRNA and miRNA, and EV DNA as potential biomarkers. Furthermore, we discuss recent developments in technology for quantitative EV analysis in the clinical setting and future perspectives toward miniaturized high-precision liquid biopsy approaches.

Clinical value and prospect of extracellular vesicle miRNAs as novel liquid biopsy molecular biomarkers of tumor

Harnessing microRNA-enriched extracellular vesicles for liquid biopsy

Prospects for liquid biopsy using microRNA and extracellular vesicles in breast cancer

MicroRNAs in extracellular vesicles: Sorting mechanisms, diagnostic value, isolation, and detection technology

Diagnostic potential of exosomal extracellular vesicles in oncology

Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers

Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy

Emerging Sensing and In Situ Detection Technologies for the Analysis of Extracellular Vesicle miRNAs

Extracellular Vesicles: Recent Developments in Technology and Perspectives for Cancer Liquid Biopsy

Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors

Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis

MicroRNAs of Tumor Extracellular Vesicles: Secretion Mechanisms and Function

Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy

Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine

Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology

Exosomes as a new frontier of cancer liquid biopsy

Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers

Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression

More than a Bubble: Extracellular Vesicle microRNAs in Head and Neck Squamous Cell Carcinoma

Recent Progress in Isolation and Detection of Extracellular Vesicles for Cancer Diagnostics

Small Extracellular Vesicles: Non-negligible Vesicles in Tumor Progression, Diagnosis, and Therapy.